Ice cream products distributed in retail stores in nine American states have been recalled due to potential Listeria contamination, according to the United States Food and Drug Administration.
The states involved were New York, Massachusetts, Connecticut, Rhode Island, Vermont, Louisiana, Florida, Texas, and New Hampshire.
The recall was initiated by Royal Ice Cream after FDA sampling revealed Listeria monocytogenes' presence on processing equipment. It has expanded its recall to include all products manufactured at the facility within expiry.
Listeria monocytogenes is an organism that can cause serious and sometimes fatal infections in the young, frail or the elderly, and others with weakened immune systems.
Although healthy individuals may only experience short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain, and diarrhea. Listeria infection can also cause miscarriages and stillbirths among pregnant women.
Officials say all affected products will have the manufacturing plant number “CT121” or “CT#121”.
The affected brands were Royal Ice Cream, Batch brand, Ronny Brook Ice cream, New Orleans Ice cream, Maple Valley Ice Cream, Art Cream, Sweet Scoops Yogurt, Gelato Fiasco, Biggy Iggy’s Ice Cream Sandwiches, Munson Chip Wich Ice Cream sandwiches, Giffords Ice cream Sandwiches, Chewy Louie Ice Cream Sandwiches, Snow Wich Ice Cream Sandwich, and Newport Creamery.
So far, no illnesses have been reported related to the product. Those who have purchased the affected products are urged to return them to the place of purchase for a full refund.


FDA Approves Mitapivat for Anemia in Thalassemia Patients
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
Asian Markets Slide as Silver Volatility, Earnings Season, and Central Bank Meetings Rattle Investors
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs
Gold Prices Stabilize in Asian Trade After Sharp Weekly Losses Amid Fed Uncertainty
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 



